Gastric Voume Assessment for Aspiration Risk in OB ERAS Patients
Pre-Operative Gastric Volume Assessment Following Carbohydrate-Loading in Obstetrical Patients Undergoing Elective Cesarean Section: A Randomized Clinical Pilot Study
In recent years, human and animal studies have found that carbohydrate-loading prior to surgery leads to improved response to surgical stress and improved postoperative well-being when compared to traditional fasting guidelines. Such positive findings have lead to the increased use of preoperative intake of carbohydrate rich drinks prior to elective surgeries.
However, one of the biggest risks during surgery when a patient is asleep is having stomach contents come up into the lungs. For this reason, a stomach that is empty or has minimal amount of contents is safest. Historically, patients have been instructed not to eat or drink for 8 hours before surgery because it was thought to lower the risk of having fluid or contents in the stomach. This is the current practice patients are asked to follow before undergoing a C-section. However, non-pregnant patients undergoing other surgeries are instructed to have carbohydrate-rich drinks because of the potential benefits. Using ultrasound, the abdomen can be simply scanned to see if there are stomach contents present before surgery. This can allow for the potential determination of what the aspiration risk may be.
What the investigators want to do is look at the safety of using carbohydrate-loading in patients having a C-section. The investigators want to make sure that patients who follow carbohydrate-loading by having a clear, sugary drink 3 hours before a C-section are not at greater risk of having a large amount of stomach contents and be at higher risk of aspirating. This will be done by taking an ultrasound scan of the stomach that will tell the investigators if there are contents in the stomach and whether there is a risk of aspiration.
Patients having an elective C-section will be randomized into two groups. The first group will follow carbohydrate-loading by having a drink of apple juice or cranberry juice cocktail the night before (800mL) and 3 hours before (400mL) the C-section. The second group will follow standard practice of not eating or drinking less than 8 hours prior to surgery. An anesthesiologist will ultrasound the stomach 1 hour before the scheduled procedure time. The first ultrasound will be completed in the supine position (lying on back). The second will be done in the right lateral decubitus position (lying on right side). This should not take more than 5-10 minutes total.
Visão geral do estudo
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Alberta
-
Calgary, Alberta, Canadá, T2N 2T9
- Foothills Medical Centre
-
Calgary, Alberta, Canadá, T1Y 6J4
- Peter Lougheed Centre
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Non-laboring pregnant women
- ≥36 weeks gestational age
- scheduled elective cesarean delivery
- ≥18 years of age
- ASA physical status I to III
- weight 50 to 120 kg
- height ≥150 cm
- Ability to understand the rationale of the study assessments
Exclusion Criteria:
- multiple gestation
- abnormal anatomy of the upper gastrointestinal tract
- gestational diabetes or pre-existing diabetes mellitus
- previous surgical procedures on the esophagus, stomach, or upper abdomen
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Triagem
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Standard Fasting Group
Ultrasound scan of gastric antrum 1 hour prior to procedure.
Patients assigned to this group will follow standard fasting procedures of no eating or drinking 8 hours prior to C-section.
|
Gastric ultrasound of the stomach antrum to assess contents 1 hour prior to C-section surgery.
Scans will be completed in both supine (lying on back) and right lateral decubitus (positions) positions.
The completion of both scans will take 5-10 minutes total
|
|
Experimental: Carbohydrate Loading Group
Ultrasound scan of gastric antrum 1 hour prior to procedure. Patients assigned to this group must stop eating 8 hours prior to their scheduled C-section time. The night before their C-section they must drink 800mL of 100% apple juice (not from concentrate) OR 800mL of cranberry juice cocktail, not both The day of their C-section, starting 3 hours before surgery and to be finished 2 hours before surgery time, patients must drink 400mL of 100% apple juice OR 400mL of cranberry juice cocktail, not both Please note:
|
Gastric ultrasound of the stomach antrum to assess contents 1 hour prior to C-section surgery.
Scans will be completed in both supine (lying on back) and right lateral decubitus (positions) positions.
The completion of both scans will take 5-10 minutes total
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Incidence of Grade 2 antrum
Prazo: 1 hour prior to C-section delivery
|
Clear fluid is evident in antrum in both supine and right lateral decubitus scanning positions
|
1 hour prior to C-section delivery
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Incidence of Grade 0 antrum
Prazo: 1 hour prior to C-section
|
Antrum appears empty in both supine and right lateral decubitus scanning positions
|
1 hour prior to C-section
|
|
Incidence of Grade 1 antrum
Prazo: 1 hour prior to C-section
|
Antrum appears empty in supine position, but clear fluid is visible in right lateral decubitus position
|
1 hour prior to C-section
|
|
Cross-sectional antral area
Prazo: 1 hour prior to C-section
|
Cross-sectional area measurement of the gastric antrum
|
1 hour prior to C-section
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- REB17-2345
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .